Local therapy of cancer with free IL-2 Willem Den OtterJohn J. L. JacobsJan Willem Koten Position Paper Open access 07 February 2008 Pages: 931 - 950
Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions Jennifer K. MulliganDeanne M. R. LathersM. Rita I. Young Original Article 04 December 2007 Pages: 951 - 961
CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients Xiaorong LinNancy H. GudgeonAnthony T. C. Chan Original Article 20 December 2007 Pages: 963 - 975
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses Richard HarropNoel DruryRobert E. Hawkins Original Article 30 November 2007 Pages: 977 - 986
Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200 A. SivaH. XinA. Kretz-Rommel Original Article 01 December 2007 Pages: 987 - 996
Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease Tao GuMehmet O. KilincNejat K. Egilmez Original Article 30 November 2007 Pages: 997 - 1005
RETRACTED ARTICLE: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF Nobuto YamamotoHirofumi SuyamaYoshihiko Koga Original Article 06 December 2007 Pages: 1007 - 1016
A33 antigen displays persistent surface expression Margaret E. AckermanCecile ChalouniK. Dane Wittrup Original Article 31 January 2008 Pages: 1017 - 1027
Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene Li-Hua XieFion Wan-Yee SinYong Xie Original Article 22 December 2007 Pages: 1029 - 1038
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma P. HerseyG. M. HallidayS. W. Menzies Original Article 21 December 2007 Pages: 1039 - 1051
Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)2 fragment of anti-CD16 antibody Anahid JewettAntonia TeruelNicholas Cacalano Original Article 10 January 2008 Pages: 1053 - 1066
In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1 Claudia GravekampBelinda LealRobert Reddick Original Article 20 December 2007 Pages: 1067 - 1077
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice Assefa WondimuTianqian ZhangDorothee Herlyn Original Article 22 December 2007 Pages: 1079 - 1089
Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression Ya-Wen HsiaoKuang-Wen LiaoRea-Min Chu Original Article 08 February 2008 Pages: 1091 - 1104